Condition
Pericarditis Acute
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 4 (1)
Trial Status
Terminated1
Unknown1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07010159Phase 2Recruiting
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
NCT04323280Phase 4TerminatedPrimary
Dexamethasone Compared to Non-steroidal Anti-inflammatory Drugs in the Treatment of Acute Pericarditis
NCT06103123Unknown
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
Showing all 3 trials